tailoring chemotherapy: r-chop dose attenuation in elderly dlbcl
Published 5 years ago • 1.8K plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
2:13
phase ii trial of split-dose r-chop for older patients with dlbcl
-
1:57
r-chop dose intensity and survival outcomes in dlbcl
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
4:16
rchop chemo
-
29:18
understanding your treatment: rchop chemotherapy
-
32:05
r-chop chemotherapy & dealing with side effects | luis’ story (2 of 3) | the patient story
-
1:40
fracture risk in older dlbcl patients after r-chop
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
4:42
comparing abvd, avd & chop chemotherapy regimens in older patients with classical hl
-
1:12
smart stop: moving away from r-chop in dlbcl
-
1:02
tailoring therapy for patients with multiple myeloma to improve outcomes
-
1:16
lotis-9 trial design: loncastuximab tesirine plus rituximab in elderly patients with dlbcl
-
1:32
management and outcomes of elderly patients with lbcl
-
2:52
reducing chemotherapy in dlbcl: flyer results
-
2:04
elderly dlbcl updates
-
4:40
reduced r-chop in favourable-prognosis dlbcl doesn't compromise outlook
-
1:46
r-chop versus r-bendamustine in fl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
0:42
targeted therapies for dlbcl treatment
-
1:36
relative dose intensity in older dlbcl patients